Biologics and Clinical Trial Matters in the Cold Chain
Add bookmark
The continued expansion of the biologics market is creating new challenges and opportunities for cold chain services. Similarly, the temperature control community is also dealing with the expanded use of clinical trial materials.
At Cold Chain IQ, we’re lucky to have some of the sharpest minds in the industry speaking at and attending our conferences. In advance of the 11th Annual Cold Chain Global Forum in Chicago, we asked some of these speakers to share their thoughts on how they plan to deal with the rise of biologics & CTM’s.
If you attend the Summit from September 30-October 4, there will be specific sessions dedicated to this topic.#
[inlinead]
